PlainRecalls
FDA Drug Moderate Class II Ongoing

Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.

Reported: May 3, 2023 Initiated: March 16, 2023 #D-0553-2023

Product Description

Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.

Reason for Recall

CGMP Deviations

Details

Units Affected
a)164 bottles; b) 198 bottles
Distribution
Nationwide with the United States
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.. Recalled by Northwind Pharmaceuticals LLC. Units affected: a)164 bottles; b) 198 bottles.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on May 3, 2023. Severity: Moderate. Recall number: D-0553-2023.